1 completed, 1 unknown. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow Stemirna Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Neoantigen mRNA Personalised Cancer in Patients With Advanced Solid Tumors Neoantigen mRNA Personalised Cancer SW1115C3 - Solid Tumor | Phase 1 | Unknown | Stemirna Therapeutics | 30 | 2022-03-18 | 2022-10-17 |
| A Phase I/II Clinical Trial in Healthy People Aged 18 Years and Above COVID-19 mRNA vaccine - COVID-19 Pandemic | Phase 1 / Phase 2 | Completed | Stemirna Therapeutics | 480 | 2021-12-03 | 2022-12-28 |
COVID-19 (1)
Australia (1) · Austria (1) · Laos (1)